Updated clinical and preliminary correlative results of ARIEL2, a Phase 2 study to identify ovarian cancer patients likely to respond to rucaparib
- Authors:
- E Swisher, J Brenton, S Kaufmann, A Oza, RL Coleman, D O'Malley, G Konecny, L Ma, M Harrell, D Visscher, AW Hendrickson, K Lin, M Raponi, E Mann, H Giordano, L Maloney, L Rolfe, I McNeish
- Journal:
- European Journal of Cancer
- Citation info:
- 50:73
- Publication date:
- 1st Nov 2014
- Full text
- DOI